Key result
Beating-heart minimally invasive MVR demonstrates feasibility with 0% mortality and no cerebral complications.
Why the study?
Minimally-invasive mitral valve replacement techniques aim to reduce incision impact, extracorporeal circulation, myocardial and pulmonary ischemia, but feasibility without aortic and vena cava cross-clamping under beating heart was not established.
Observational (n=11)
No
BACKGROUND: The primary aims of minimally-invasive cardiac valve surgery are to lessen the impact of the incision, extracorporeal circulation, myocardial ischemia, and pulmonary ischemia, to obtain satisfactory therapeutic results, and to allow a quicker rehabilitation. In this study, the feasibility of minimally-invasive mitral valve replacements without ascending aorta and vena cava cross-clamping under beating heart was evaluated by surveying 11 patients. METHODS: Preoperative risk factors, intraoperative techniques, and postoperative complications were surveyed and evaluated for one year (April 1, 2009 to March 30, 2010) in 11 patients who had undergone beating-heart mitral valve replacement surgery at The People's Hospital of Guangxi Zhuang Autonomous Region. Minithoracotomy and femoral arterial cannulation procedures were used in the surgeries for cardiopulmonary bypass (CPB) without ascending aorta and vena cava cross-clamping. RESULTS: The operations were performed successfully in all 11 patients. The CPB time was 52.80 ± 11.36 minutes; the mean postoperative mechanical ventilation assistance time was 8.20 ± 2.84 hours; and the mean transfusion volume of red cells was 2.20 ± 1.04 units. There were no cerebral complications, no periprosthetic leakage, no occurrence of permanent high-degree atrioventricular blockage, and no mortality. CONCLUSION: Mitral valve replacement on the beating heart using a minithoracotomy and femoral arterial cannulation for CPB without ascending aorta and vena cava crossclamping under pulmonary ventilation is feasible. A larger number of patients are required to further characterize the efficacy and safety of this procedure.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2012) conducted an observational in Rheumatic heart disease requiring mitral valve replacement (n=11). Minimally-invasive mitral valve replacement under on-pump beating heart and lung perfusion/ventilation without cross-clamping was evaluated on Surgical feasibility and safety (mortality, cerebral complications, cardiopulmonary bypass time, and ventilation assistance time). Minimally invasive mitral valve replacement on the beating heart with lung perfusion and ventilation via minithoracotomy was successfully performed in 11 patients with 0% mortality and no cerebral complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: